Literature DB >> 23240672

High-grade endometrial carcinomas - strategies for typing.

Robert A Soslow1.   

Abstract

High-grade endometrial carcinomas are subject to low rates of interobserver diagnostic agreement; this may be a result of the existence of morphologically ambiguous carcinomas, many of which are microsatellite instability-high. High-grade endometrial carcinomas with prototypic morphology have characteristic genotypes and immunohistochemical profiles. Assays accounting for these features may be applied to morphologically ambiguous carcinomas in the hope that the results will provide some clarity about a tumour's origin and expected clinical outcome, and even whether tumour progression has occurred. It is important to be able to demonstrate that morphologically based diagnoses are strongly linked not only to clinical outcomes, but also to genetic signatures and expression profiles. There are still numerous persistent problems in tumour classification that will require a critical evaluation of the type and strength of evidence needed to refine diagnostic algorithms.
© 2012 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23240672     DOI: 10.1111/his.12029

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  12 in total

1.  Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.

Authors:  Oluwole Fadare; Vinita Parkash; Katja Gwin; Krisztina Z Hanley; Elke A Jarboe; Sharon X Liang; Charles M Quick; Wenxin Zheng; Kojo R Rawish; Jonathan L Hecht; Mohamed M Desouki
Journal:  Hum Pathol       Date:  2013-10-10       Impact factor: 3.466

Review 2.  The emerging genomic landscape of endometrial cancer.

Authors:  Matthieu Le Gallo; Daphne W Bell
Journal:  Clin Chem       Date:  2013-10-29       Impact factor: 8.327

3.  Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor.

Authors:  Lei Zhang; David Shimizu; Jeffrey L Killeen; Stacey A Honda; Di Lu; Alexander Stanoyevitch; Fritz Lin; Beverly Wang; Edwin S Monuki; Michele Carbone
Journal:  Hum Pathol       Date:  2016-03-11       Impact factor: 3.466

Review 4.  Practical issues in the diagnosis of serous carcinoma of the endometrium.

Authors:  Sonia Gatius; Xavier Matias-Guiu
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

5.  Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.

Authors:  Shaomin Hu; Jeff L Hinson; Rahul Matnani; Michael L Cibull; Rouzan G Karabakhtsian
Journal:  Mod Pathol       Date:  2017-10-06       Impact factor: 7.842

6.  TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.

Authors:  Anne M Schultheis; Luciano G Martelotto; Maria R De Filippo; Salvatore Piscuglio; Charlotte K Y Ng; Yaser R Hussein; Jorge S Reis-Filho; Robert A Soslow; Britta Weigelt
Journal:  Int J Gynecol Pathol       Date:  2016-07       Impact factor: 2.762

Review 7.  Impact of Molecular Classification on Treatment Paradigms in Uterine Cancers.

Authors:  Casey M Cosgrove; David Barrington; Floor J Backes
Journal:  Curr Oncol Rep       Date:  2021-05-03       Impact factor: 5.075

8.  Comprehensive Analysis of the Prognostic Signature of Mutation-Derived Genome Instability-Related lncRNAs for Patients With Endometrial Cancer.

Authors:  Jinhui Liu; Guoliang Cui; Jun Ye; Yutong Wang; Can Wang; Jianling Bai
Journal:  Front Cell Dev Biol       Date:  2022-04-01

9.  Endometrial cancer with a POLE mutation progresses frequently through the type I pathway despite its high-grade endometrioid morphology: a cohort study at a single institution in Japan.

Authors:  Mahina Monsur; Munekage Yamaguchi; Hironori Tashiro; Kumiko Yoshinobu; Fumitaka Saito; Chimeddulam Erdenebaatar; Chenyan Li; Yutaka Iwagoi; Takashi Ohba; Ken-Ichi Iyama; Hidetaka Katabuchi
Journal:  Med Mol Morphol       Date:  2021-01-05       Impact factor: 2.309

Review 10.  Targeting Wnt Signaling in Endometrial Cancer.

Authors:  Iram Fatima; Susmita Barman; Rajani Rai; Kristina W W Thiel; Vishal Chandra
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.